JZUS - Journal of Zhejiang University SCIENCE

Journal of Zhejiang University SCIENCE A 2003 Vol.4 No.5 P.607-611

http://doi.org/10.1631/jzus.2003.0607

Anticoagulation therapy in intra-aortic balloon counterpulsation: Does IABP really need anti-coagulation?

Author(s): JIANG Chen-yang, ZHAO Li-li, WANG Jian-an, SAN Jiang, MOHAMMOD Balgaith
Affiliation(s): Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou 310016, China; more
Corresponding email(s): jiangchenyang@hotmail.com
Key Words: Intra-aortic balloon pump, Anti-coagulation, Ischemia

Share this article to： More

Abstract: Objective: To investigate if intra-aortic balloon pump (IABP) is contraindicated without anticoagulation therapy. Methods: Some 153 IABP patients in the King Abdulaziz Cardiac Center (KSA) were randomly assigned into two groups. Anticoagulation group (Group A) consisted of 71 patients who were given heparin intravenously with target aPTT 50-70 seconds. Non-anticoagulation group (Group B) consisted of 82 patients without intravenous heparin during balloon pumping. Hematological parameters including platelet count, D-dimer, Plasminogen activator inhibitor-1 (PAI-1) and fibrinogen degradation products (FDP) were checked respectively at the point of baseline, 24 hours, 48 hours and 24 hours post IABP counterpulsation. Clot deposits on balloon surface, vascular complications from IABP including bleeding and limb ischemia were recorded. Results: Platelet count and PAI-1 level decreased at 24 hours and 48 hours in both groups (P<0.05). D-dimer and FDP level increased at 24 hours and 48 hours in both groups (P<0.05), but returned to the baseline level 24 hours post IABP removal (P>0.05). Three patients in Group A and 2 patients in Group B developed minor limb ischemia(P>0.05). No major limb ischemia in either group. Two patients in Group A suffered major bleeding and required blood transfusion or surgical intervention, whereas no patient had major bleeding in Group B. Eight patients had minor bleeding in Group A, but only 2 patients in Group B (P<0.05). No clot deposit developed on IABP surface in either group. Conclusion: IABP is safe without routine anticoagulation therapy. Selecting appropriate artery approach and early detection intervention are key methods for preventing complications.

Reference

[1]Alderman,J.D., Gabliani,G.I. and McCabe,C.H., 1987. Inccidence and management of limb ischemia with percutaneous wire-guided intra-aortic balloon catheters. J Am Coll Cardiol, 9:524-530.

[2]Cohen,M., Dawson,M.S., Kopistansky, C. and McBride,R., 2000. Sex and other predictors of intra-aortic balloon pump complication: prospective study of 1119 consecutive patients. Am Heart J,139:282-287.

[3]Ferguson, J.J. 3rd., Cohen, M., Freedman, R.J. Jr., Stone, G.W., Miller, M.F., Joseph, D.L. and Okman, E.M., 2001. The current practice of intra-aortic balloon counterpulsation: Results from the Benchmark Registry. J Am Coll Cardiol, 38(5):1456-1462.

[4]Funk,M., Gleason,J. and Foell,D., 1989. Lower limb ischemia related to use of the intra-aortic balloon pump. Heart Lung,18:542-552.

[5]Iverson,L.I.G., Herfindahl,G. and Ecker,R.R., 1988. Vascular complications of intra-aortic balloon counterpulsation. Am J surg,123:1207-1212.

[6]Kleiman,N.S.,Lincoff,M., Flaker,G.S., Pieper,K.S., Wilcox,R.G., Berdan,L.G., Lorenz,T.J., Cokkinos,D.V., Somoons, M. and Boersma,E., 2000. Early, percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes.Circulation, 101:751-757.

[7]Kuki,S., Taniguchi,K., Msai,T., Yoshida,K., Yamamoto,K. and Matsuda, H., 2001. Usefulness of the low profile "True 8" intra-aortic balloon pumping preventing limb ischemia. ASAIO J, 47(6):611-614.

[8]Li,W.X. and Zhou,Q.W., 2001. Application of intra-aortic balloon counterpulsation in coronary artery disease surgery. K X Med Uni J, 18(1):42-44 (in Chinese).

[9]Matthew,T.R., 2000. Manual of cardiovascular medicine. Lippincott Williams & Wilkin, p.687-699.

[10]Mueller,X.M., Tevaearai, H.T. and Von,S.K., 1999. Intra-aortic balloon: evaluation of heparin-coating under various experimental conditions. Int J Artif Organs,22(9):625-628.

[11]Ohley,W.J., Antonelli, L. and Leschinsky,B., 1998. Influence of catheter and arterial diameter on flow distal to an intra-aortic balloon insertion site: a theoretic examination and in vitro assessment. ASAIO J,44(6):786-793.

[12]Stavarski,D.H., 1996. Complications of intra-aortic balloon pumping.Preventable or not preventable Crit Care Nurs Clin North Am, 8(4):409-421.

[13]Steven, P.M., Brian, P.G. and Eric, J.T., 2000. Manual of cardiovascular medicine. Lippincoot Williams & Wilkins, p.687-699.

[14]Suzanne,J.F.,Alfred.S.,Ubeydullah,D.,Scott,W.S.,Anselmo,A. and Timothy,G., 1997. Hemastatic assessment of patients undergoing intra-aortic balloon pump therapy.J E Corpo Tech, 29(2):78-82.

[15]Sato,K., Tokairin, H. and Kato, M., 2001. Two patients treated with intra-aortic balloon pump counterpulsation for subarachnoid hemorrhage. Masue, 50(8):859-862.

[16]Winters,K.J., Smith,S.C., Cohen,M., Kopistansky, C. and McBride, R., 1999. Reduction in ischemic vascular complications and balloon leak with a hydrophilic-coated intra-aortic balloon catheter. Cathet Cardiovasc Intervent,46:357-362.

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Yolanda Chou<ronerone00690@hotmail.com>

2015-02-19 20:58:05

Thanks for your contribution

Similar articles

- Go to

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Reference